June 30th
June 27th
June 1st
May 28th
May 26th
May 19th
April 28th
April 27th
April 24th
March 31st
No video for Fibrillation is available at this time.
Sanofi-Aventis heart drug approved - Boston Globe
NEW YORK - Sanofi- Aventis SA said its drug Multaq, which treats irregular heart rhythms, received marketing approval after a delay of nearly three years. Multaq is intended to treat atrial flutter and atrial fibrillation, a disease in which the ...
Atrial Fibrillation In Endurance Athletes Still Poses Problems For ... - Science Daily
"It's for this reason that sports medicine has focused on pre-participation screening," says Dr Luis Mont from the Hospital Clínic de Barcelona, Spain, "in an attempt to detect any hidden heart disease." On the other hand, disturbances in heart ...
FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial ... - Medical News Today
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment ...
FDA approves new fibrillation drug - United Press International
WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration announced approval Thursday of Multaq tablets to help maintain normal heart rhythms in patients with heart disorders. The FDA said Multaq (dronedarone) is designed to treat atrial ...
FDA Approves Multaq for Patients with Atrial Fibrillation or Atrial ... - Phramalive.com
- Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - PARIS, July 02, 2009 /PRNewswire-FirstCall/ --Sanofi-aventis announced today that the U.S. Food and Drug Administration ...
Do you prefer to listen to your fibrillation gossip? Check out Podzy Podcast Directory > Fibrillation.
Looking for fibrillation related products, then look no further. Try our new Fibrillation Shop.